Disease/Infection News

RSS

Inhalable nanobody shows potent anti-SARS-CoV-2 activity in vivo

Researchers have developed a stable and ultrapotent homotrimeric Pittsburgh inhalable Nanobody 21 (PiN-21) against SARS-CoV-2 infection in Syrian hamsters. They demonstrated the high therapeutic efficacy of this homotrimeric Nb, leveraging both intranasal and aerosol delivery.

26 Feb 2021

Single dose of Pfizer BioNTech vaccine can reduce asymptomatic SARS-CoV-2 infections

New data from Addenbrooke's Hospital in Cambridge suggests that a single dose of the Pfizer BioNTech vaccine can reduce by four-fold the number of asymptomatic SARS-CoV-2 infections.

26 Feb 2021

What is the impact of demographics and air quality on COVID-19 mortality?

A new piece of research was conducted using a wide range of variables related to demographic and environmental factors in New York State (NYS), USA. NYS consists of urban and ethnically diverse counties, some of which are population-dense while others are population-sparse.

26 Feb 2021

Is one dose of Pfizer-BioNTech mRNA vaccine for COVID-19 convalescents sufficient?

Researchers evaluated the immune response in a cohort of 1,089 healthcare workers who received the Pfizer-BioNTech vaccine in Southern California.

26 Feb 2021

Mandatory public health measures to combat COVID-19 are more effective, says study

In a new study, researchers at Lundberg Health Advocates and the Johns Hopkins Bloomberg School of Public Health in the U.S. compared mandatory and voluntary implementations of shelter-in-place policies. They assessed their respective bearings on COVID-19 mortality, equity, and economic outcomes.

26 Feb 2021

As Covid surged, vaccines came too late for at least 400 medical workers

As health care workers in the U.S. began lining up for their first coronavirus vaccines on Dec. 14, Esmeralda Campos-Loredo was already fighting for oxygen.

26 Feb 2021

Immunologists map unknown biological machinery to produce memory T cells

Immunologists at St. Jude Children's Research Hospital have mapped the previously unknown biological machinery by which the immune system generates T cells that kill bacteria, viruses and tumor cells.

26 Feb 2021

Researchers investigate the duration of the immune response to SARS-CoV-2

The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration in August 2020, is within 60 days of the onset of symptoms, according to a new Penn State-led study.

26 Feb 2021

New tool identifies security and privacy risks associated with COVID-19 contact tracing apps

Researchers have developed a tool to identify security and privacy risks associated with Covid-19 contact tracing apps.

26 Feb 2021

Study: Stay-at-home ordinance had positive effects on health and well-being of residents

A study by physiology researchers at The University of Texas at El Paso found that El Paso's stay-at-home ordinance due to the COVID-19 pandemic had positive effects on the health and well-being of the region's residents.

26 Feb 2021

Researchers propose new mechanism to promote access to COVID-19 vaccines

Although the value of vaccines for COVID-19 may seem obvious, government action and investment in vaccines have not been commensurate with the enormous scale of benefits they offer, argue Juan Camilo Castillo and colleagues in this Policy Forum.

26 Feb 2021

New test can detect viral infections in uncultured bacteria

The pandemic has made clear the threat that some viruses pose to people. But viruses can also infect life-sustaining bacteria and a Johns Hopkins University-led team has developed a test to determine if bacteria are sick, similar to the one used to test humans for COVID-19.

26 Feb 2021

LOINC receives additional federal funding to respond to COVID-19 pandemic

LOINC® at Regenstrief, an international health data standard critical to health information exchange, has received additional federal funding to support efforts to respond to the COVID-19 pandemic and future public health needs.

26 Feb 2021

Programmed magnetic nanobeads rapidly diagnose COVID-19

COVID-19 can be diagnosed in 55 minutes or less with the help of programmed magnetic nanobeads and a diagnostic tool that plugs into an off-the-shelf cell phone, according to Rice University engineers.

26 Feb 2021

Survey: Black people more likely to adhere to public health guidelines due to disparities

America's stark racial disparities in health care have been exposed by COVID-19, but a new study from Michigan State University suggests that Black individuals are more likely than conservative White people to adhere to public health standards due to disparities.

26 Feb 2021

Study examines the future psyche of post-COVID-19 traveler

Our deep-rooted survival instinct for disease avoidance could make us less willing to embrace strangers and take foreign travel risks.

26 Feb 2021

Study explains the evolution of SARS-CoV-2 virus

As COVID-19 sweeps the world, related viruses quietly circulate among wild animals. A new study shows how SARS-CoV-2, the virus that causes COVID-19, and SARS-CoV-1, which caused the 2003 SARS outbreak, are related to each other.

26 Feb 2021

Study shows why SARS-CoV-2 is more infectious than SARS-CoV-1

Coronavirus outbreaks have occurred periodically, but none have been as devastating as the COVID-19 pandemic.

26 Feb 2021

Study: Rural Americans are less likely to follow COVID-19 prevention behaviors

Timothy Callaghan, PhD, and Alva Ferdinand, DrPH, JD, from the Southwest Rural Health Research Center at Texas A&M University School of Public Health, joined colleagues in the first national study of how often people in urban and rural areas in the United States follow COVID-19 guidelines

26 Feb 2021

Researchers examine effectiveness of Pfizer vaccine against COVID-19

A major study, conducted in collaboration with researchers from Harvard University, examined data on 600,000 vaccinated individuals in Israel, along with 600,000 matched unvaccinated controls.

26 Feb 2021